Chlodantane

Chlodantane (developmental code name ADK-910) is a drug described as an adaptogen or actoprotector "of the estrogen activity type" that was developed in Russia and was never marketed.^[1][2] It is an adamantane derivative and is closely related to bromantane (N-(2-adamantyl)-N-(para-bromophenyl)amine) and other adamantanes.^[2][1] It has been said to improve physical performance.^[2] However, only animal or cell culture research has been conducted and it has not been studied in humans.^[2] The drug is described as having a broader spectrum of activity than bromantane.^[1] It also has immunostimulant effects that are said to be more pronounced than those of bromantane.^[1]

Chlodantane

Clinical data
Other names	ADK-910; Chlodantan; N-(2-Adamantyl)-N-(para-chlorobenzoyl)amine; 2-(para-Chlorobenzoylamino)adamantane
Identifiers
IUPAC name N-(2-adamantyl)-4-chlorobenzamide
CAS Number	185384-80-9 Y
PubChem CID	959689
ChemSpider	832832
Chemical and physical data
Formula	C17H20ClNO
Molar mass	289.80 g·mol−1
3D model (JSmol)	Interactive image
SMILES C1C2CC3CC1CC(C2)C3NC(=O)C4=CC=C(C=C4)Cl
InChI InChI=1S/C17H20ClNO/c18-15-3-1-12(2-4-15)17(20)19-16-13-6-10-5-11(8-13)9-14(16)7-10/h1-4,10-11,13-14,16H,5-9H2,(H,19,20) Key:VOHIYJJUKAUCCU-UHFFFAOYSA-N

See also

• List of Russian drugs